Not recruiting
Non-small cell lung cancer+17
Not recruitingStudy on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer
Registered drugNo placebo
Study on the Safety and Effects of ATL001 and Pembrolizumab in Adults with Advanced Non-Small Cell Lung Cancer
Registered drugNo placebo
- Disease:Non-small cell lung cancerNon-small cell lung cancer stage III+16
- Substances:ATL001Pembrolizumab
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:ATL001
- Sponsor:Achilles Therapeutics UK Limited




